Investors optimistic about continued biotech and medtech IPO resurgence in 2025
Though still below boom levels seen a few years ago, 2024 compares favourably to 2023, and signs suggest that growth will continue into 2025.
Though still below boom levels seen a few years ago, 2024 compares favourably to 2023, and signs suggest that growth will continue into 2025.
What's Your Reaction?
